Publication | Closed Access

Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease

Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver PhysiologyFat ContentPathologyHepatology InflammationLiver DiseaseFatty Liver DiseaseMetabolismMedicineDose–response RelationshipHealth Sciences